Literature DB >> 16622477

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

Giuseppe Pantaleo1, Alexandre Harari.   

Abstract

At present, we only have indirect knowledge of the protective role of antigen-specific T cells in human viral infections, and it has been difficult to show a direct correlation between quantitative and qualitative measures of T-cell immunity and virus-associated diseases. However, as described in this Opinion article, recent advances in the characterization of T-cell functions and in the development of standardized T-cell assays have led to the identification of distinct functional signatures of T-cell responses that correlate with levels of viral replication and disease activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622477     DOI: 10.1038/nri1840

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  84 in total

1.  Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Authors:  Shoji Asakura; Daigo Hashimoto; Shuichiro Takashima; Haruko Sugiyama; Yoshinobu Maeda; Koichi Akashi; Mitsune Tanimoto; Takanori Teshima
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Polyfunctional responses by human T cells result from sequential release of cytokines.

Authors:  Qing Han; Neda Bagheri; Elizabeth M Bradshaw; David A Hafler; Douglas A Lauffenburger; J Christopher Love
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.

Authors:  David Cervi; Yuval Shaked; Mehran Haeri; Tatiana Usenko; Christina R Lee; Jody J Haigh; Andras Nagy; Robert S Kerbel; Eitan Yefenof; Yaacov Ben-David
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 4.  HIV vaccines: lessons learned and the way forward.

Authors:  Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

5.  Complementarity-determining region 3 size spectratypes of T cell receptor beta chains in CD8+ T cells following antiviral treatment of chronic hepatitis B.

Authors:  Shi-Wu Ma; Yong-Yin Li; Guang-Wen Zhang; Xuan Huang; Jian Sun; Chris Li; William G H Abbott; Jin-Lin Hou
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

6.  Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype.

Authors:  Alexandre Harari; Cristina Cellerai; Felicitas Bellutti Enders; Josef Köstler; Laura Codarri; Gonzalo Tapia; Onur Boyman; Erika Castro; Silvana Gaudieri; Ian James; Mina John; Ralf Wagner; Simon Mallal; Giuseppe Pantaleo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Immuno-hybridization chain reaction for enhancing detection of individual cytokine-secreting human peripheral mononuclear cells.

Authors:  Jonghoon Choi; Kerry Routenberg Love; Yuan Gong; Todd M Gierahn; J Christopher Love
Journal:  Anal Chem       Date:  2011-08-15       Impact factor: 6.986

Review 8.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

9.  Clinical significance of interleukin-2/gamma interferon ratios in Mycobacterium tuberculosis-specific T-cell signatures.

Authors:  Franziska Suter-Riniker; Antonia Berger; Désirée Mayor; Pascal Bittel; Patricia Iseli; Thomas Bodmer
Journal:  Clin Vaccine Immunol       Date:  2011-06-01

10.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.